Shares of Sun Pharmaceutical slipped over 2 per cent Thursday, a day after markets regulator Sebi said it was examining the whistleblower complaint against the company.
The stock dropped 2.12 per cent to settle at Rs 422.15 on the BSE. During the trading session, the scrip touched a low of Rs 418, a decline of 3.08 per cent.
On the NSE, the stock fell 2.19 per cent to Rs 422 from the previous close. It had touched a low of Rs 418, down 3.11 per cent, during the trading session.
In terms of equity volume, over 13 lakh shares were traded on the BSE, while over 1.6 crore units changed hands on the NSE.
When asked about the whistleblower complaint against Sun Pharma, Sebi Chairman Ajay Tyagi on Wednesday said, "There is a whistleblower complaint which we are examining. I have nothing more to add."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app